293 related articles for article (PubMed ID: 38177560)
41. An Insight into Cholangiocarcinoma and Recent Advances in its Treatment.
Sahu R; Sharma P; Kumar A
J Gastrointest Cancer; 2023 Mar; 54(1):213-226. PubMed ID: 35023010
[TBL] [Abstract][Full Text] [Related]
42. Multidisciplinary approaches to intrahepatic cholangiocarcinoma.
Maithel SK; Gamblin TC; Kamel I; Corona-Villalobos CP; Thomas M; Pawlik TM
Cancer; 2013 Nov; 119(22):3929-42. PubMed ID: 23963845
[TBL] [Abstract][Full Text] [Related]
43. Panitumumab in combination with gemcitabine and oxaliplatin does not prolong survival in wild-type KRAS advanced biliary tract cancer: A randomized phase 2 trial (Vecti-BIL study).
Leone F; Marino D; Cereda S; Filippi R; Belli C; Spadi R; Nasti G; Montano M; Amatu A; Aprile G; Cagnazzo C; Fasola G; Siena S; Ciuffreda L; Reni M; Aglietta M
Cancer; 2016 Feb; 122(4):574-81. PubMed ID: 26540314
[TBL] [Abstract][Full Text] [Related]
44. Distal Cholangiocarcinoma and Pancreas Adenocarcinoma: Are They Really the Same Disease? A 13-Institution Study from the US Extrahepatic Biliary Malignancy Consortium and the Central Pancreas Consortium.
Ethun CG; Lopez-Aguiar AG; Pawlik TM; Poultsides G; Idrees K; Fields RC; Weber SM; Cho C; Martin RC; Scoggins CR; Shen P; Schmidt C; Hatzaras I; Bentrem D; Ahmad S; Abbott D; Kim HJ; Merchant N; Staley CA; Kooby DA; Maithel SK
J Am Coll Surg; 2017 Apr; 224(4):406-413. PubMed ID: 28017812
[TBL] [Abstract][Full Text] [Related]
45. Advances in pharmacotherapy for cholangiocarcinoma: from conventional therapies to targeted drugs.
Spolverato G; Glavas D; Hewitt DB; Brown ZJ; Capelli G; Bergamo F; Rizzato MD; Pawlik TM
Expert Opin Pharmacother; 2022 Mar; 23(4):473-481. PubMed ID: 34964678
[TBL] [Abstract][Full Text] [Related]
46. The diagnosis and treatment of cholangiocarcinoma.
Vogel A; Wege H; Caca K; Nashan B; Neumann U
Dtsch Arztebl Int; 2014 Oct; 111(44):748-54. PubMed ID: 25412632
[TBL] [Abstract][Full Text] [Related]
47. A review of the clinical diagnosis and therapy of cholangiocarcinoma.
Yao D; Kunam VK; Li X
J Int Med Res; 2014 Feb; 42(1):3-16. PubMed ID: 24366497
[TBL] [Abstract][Full Text] [Related]
48. Cholangiocarcinoma: Current opinion on clinical practice diagnostic and therapeutic algorithms: A review of the literature and a long-standing experience of a referral center.
Brandi G; Venturi M; Pantaleo MA; Ercolani G;
Dig Liver Dis; 2016 Mar; 48(3):231-41. PubMed ID: 26769568
[TBL] [Abstract][Full Text] [Related]
49. Immune checkpoint inhibitors in cholangiocarcinoma.
Beri N
Immunotherapy; 2023 May; 15(7):541-551. PubMed ID: 37096964
[TBL] [Abstract][Full Text] [Related]
50. Liver transplantation for perihilar cholangiocarcinoma.
Gores GJ; Darwish Murad S; Heimbach JK; Rosen CB
Dig Dis; 2013; 31(1):126-9. PubMed ID: 23797134
[TBL] [Abstract][Full Text] [Related]
51. Update on the Diagnosis and Treatment of Cholangiocarcinoma.
Doherty B; Nambudiri VE; Palmer WC
Curr Gastroenterol Rep; 2017 Jan; 19(1):2. PubMed ID: 28110453
[TBL] [Abstract][Full Text] [Related]
52. Combined photodynamic therapy with systemic chemotherapy for unresectable cholangiocarcinoma.
Gonzalez-Carmona MA; Bolch M; Jansen C; Vogt A; Sampels M; Mohr RU; van Beekum K; Mahn R; Praktiknjo M; Nattermann J; Trebicka J; Branchi V; Matthaei H; Manekeller S; Kalff JC; Strassburg CP; Weismüller TJ
Aliment Pharmacol Ther; 2019 Feb; 49(4):437-447. PubMed ID: 30637783
[TBL] [Abstract][Full Text] [Related]
53. Cholangiocarcinoma.
Khan AS; Dageforde LA
Surg Clin North Am; 2019 Apr; 99(2):315-335. PubMed ID: 30846037
[TBL] [Abstract][Full Text] [Related]
54. [Gallbladder carcinoma and extrahepatic cholangiocarcinoma].
Seeger N; Grochola LF; Breitenstein S
Ther Umsch; 2021; 78(10):589-596. PubMed ID: 34844437
[TBL] [Abstract][Full Text] [Related]
55. Cholangiocarcinoma: a site-specific update on the current state of surgical management and multi-modality therapy.
Turgeon MK; Maithel SK
Chin Clin Oncol; 2020 Feb; 9(1):4. PubMed ID: 31500433
[TBL] [Abstract][Full Text] [Related]
56. Update on the management of cholangiocarcinoma.
Skipworth JR; Keane MG; Pereira SP
Dig Dis; 2014; 32(5):570-8. PubMed ID: 25034290
[TBL] [Abstract][Full Text] [Related]
57. Adjuvant surgery for advanced extrahepatic cholangiocarcinoma.
Oshiro Y; Takahashi K; Sasaki R; Kondo T; Sakashita S; Ohkohchi N
World J Gastroenterol; 2013 Oct; 19(40):6934-8. PubMed ID: 24187473
[TBL] [Abstract][Full Text] [Related]
58. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
[TBL] [Abstract][Full Text] [Related]
59. Novel multimodality treatment sequencing for extrahepatic (mid and distal) cholangiocarcinoma.
Turaga KK; Tsai S; Wiebe LA; Evans DB; Gamblin TC
Ann Surg Oncol; 2013 Apr; 20(4):1230-9. PubMed ID: 23064778
[TBL] [Abstract][Full Text] [Related]
60. Current Updates on Diagnosis and Management of Cholangiocarcinoma: from Surgery to Targeted Therapy.
Surya H; Abdullah M; Nelwan EJ; Syam AF; Prasetya IB; Stefanus B; Rumende CM; Shatri H
Acta Med Indones; 2023 Jul; 55(3):361-370. PubMed ID: 37915146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
